Hypothesis

Impaired nocturnal glymphatic clearance of corticotropin-releasing factor (CRF) and related stress peptides during slow-wave sleep leads to their accumulation in the extracellular space of the amygdala and connected prefrontal regions, which sensitizes CRF receptors, enhances calcium signaling, and drives maladaptive potentiation of amygdala‑vmPFC circuits, thereby increasing anxiety‑like behavior, especially in older adults with reduced slow-wave sleep.

Mechanistic Reasoning

During slow-wave sleep, the interstitial space expands ~60%, facilitating convective influx of cerebrospinal fluid and efflux of interstitial solutes via the glymphatic pathway [3]. While this system is best known for clearing metabolic waste such as amyloid‑beta and tau [5], it also clears neuropeptides that are released during waking stress. CRF is released from hypothalamic and extra‑hypothalamic neurons during arousal and acts on CRF‑type 1 receptors in the central amygdala to increase intracellular calcium and promote long‑term potentiation [6]. If glymphatic flow is diminished—by aging, sleep fragmentation, or experimental suppression—extracellular CRF fails to be cleared, leading to prolonged receptor activation.

Elevated CRF sustains calcium‑dependent signaling pathways that phosphorylate AMPA receptors and strengthen synaptic inputs from the basolateral amygdala to the central nucleus, while simultaneously weakening top‑down inhibitory control from the ventromedial prefrontal cortex (vmPFC) via reduced GABAergic tone. This dual shift mirrors the connectivity changes observed after sleep deprivation: reduced amygdala‑vmPFC negative coupling and heightened amygdala‑insula synchrony [1]. In aged individuals, baseline slow‑wave sleep is already reduced [3], creating a chronic state of insufficient CRF clearance that cumulatively heightens amygdala excitability and lowers the threshold for fear expression.

Thus, the nightly glymphatic “autopsy” is not merely removing waste; it actively edits the peptidergic landscape that determines which neural configurations persist. Failure to perform this edit permits stress‑peptide‑driven maladaptive wiring to survive, manifesting as heightened anxiety.

Testable Predictions

1. CSF CRF levels will rise after selective suppression of slow-wave sleep (e.g., acoustic disruption) in young healthy participants and will correlate with increased amygdala‑insula functional connectivity measured by fMRI the next morning [1].
2. Genetic or pharmacological reduction of glymphatic inflow (e.g., AQP4 knockout or intracerebroventricular infusion of a glymphatic inhibitor) will elevate extracellular CRF in the amygdala of mice and produce increased anxiety‑like behavior in the elevated plus maze, an effect that should be blocked by central administration of a CRF‑type 1 receptor antagonist.
3. In older adults, individual differences in slow‑wave sleep proportion will predict inverse CSF CRF concentrations; lower slow‑wave sleep will associate with higher CSF CRF and stronger positive amygdala‑insula coupling, a relationship that should vanish after statistically controlling for CSF CRF levels.
4. Acute enhancement of glymphatic flow via intranasal cerebrospinal fluid infusion or low‑frequency ultrasound will reduce extracellular CRF and normalize amygdala‑vmPFC anti‑correlation in sleep‑deprived subjects, accompanied by decreased self‑reported state anxiety.

Falsifiability

If experimental elevation of glymphatic clearance (by any of the methods above) fails to lower extracellular CRF or does not ameliorate anxiety‑like phenotypes despite verified increases in interstitial fluid flow, the hypothesis that CRF accumulation mediates sleep‑loss‑related amygdala sensitization would be refuted. Similarly, if CRF receptor antagonism does not rescue anxiety phenotypes in models with impaired glymphatic function, the causal link between CRF and circuit pathology would be undermined.

References (inline)

[1] https://pubmed.ncbi.nlm.nih.gov/29272546/ [2] https://pmc.ncbi.nlm.nih.gov/articles/PMC3792375/ [3] https://pmc.ncbi.nlm.nih.gov/articles/PMC10452251/ [4] https://www.myamericannurse.com/sleep-and-the-glymphatic-system/ [5] https://doi.org/10.1084/jem.20211275 [6] https://pmc.ncbi.nlm.nih.gov/articles/PMC3259347/